Search for: "In Re Super Trading Co."
Results 41 - 60
of 275
Sorted by Relevance
|
Sort by Date
25 Jun 2009, 4:29 am
Super. [read post]
4 Mar 2023, 4:00 am
Super. 559 (App. [read post]
2 Sep 2009, 11:22 pm
Super. [read post]
1 Feb 2007, 6:07 am
Super. [read post]
13 Jun 2008, 12:12 pm
Super. [read post]
3 Jul 2008, 7:26 pm
Super. [read post]
12 Mar 2015, 4:31 am
In 10 years the stock price has grown from about $45 per share.It's a highly diversified insurance company, with international operations.Trust me that this little administrative fine won't even make news up to the C-suite.And it's nice that as part of their penalty the company gets a tax deduction.As I said in my earlier piece about Texas' Supreme Court's ruling in In Re Crawford & Co. , don't get hurt in Texas.And invest in Texas workers'… [read post]
26 Feb 2018, 11:36 am
The Board analyzes the facts as they relate to the relevant factors set out in In re E. [read post]
26 Feb 2018, 11:36 am
The Board analyzes the facts as they relate to the relevant factors set out in In re E. [read post]
23 Sep 2007, 2:28 pm
In re Vioxx Prods. [read post]
5 Feb 2009, 12:19 pm
Purdue Pharma Co., 297 F. [read post]
3 May 2012, 5:04 pm
” In re Glosser Bros., 382 Pa. [read post]
29 Apr 2008, 7:28 am
Super. [read post]
14 Mar 2024, 3:51 am
We’re not super-consumers with expertise in particular markets. [read post]
15 Apr 2020, 3:03 am
” Companies should be prepared for even more shareholder resolutions on political disclosures and more investor pressure to disclose all of their political spending, particularly those corporate funds channeled into so-called “dark money” vehicles: trade associations and 501(c)(4)s (organizations originally designed to promote social welfare and cause-related activities, to help educate the public), as well as the 527 Super-PACs that enable corporations to… [read post]
7 Mar 2007, 11:09 am
Co., 329 F. [read post]
11 Jun 2014, 8:28 am
Trade Efficiency for Service. [read post]
16 Aug 2007, 7:20 am
While we almost always have questions relating to the plaintiff's treatment, usually what we're even more interested in is what the prescriber thinks of the drug itself.Was s/he already aware of the claimed risk? [read post]
20 Mar 2009, 2:05 am
App. 1971); In re Guidant Corp. [read post]
18 Jul 2014, 11:55 am
In re Darvocet, Darvon & Propoxyphene Products Liability Litigation, 2012 WL 3842045, at *7-8 (E.D. [read post]
